Health Care Reform to Boost Hospital Demand for Molecular Diagnostics
MDx provides a highly sensitive, fully automated approach that streamlines the diagnosis-to-treatment process.
Read MorePosted by Judy O'Rourke | Apr 23, 2013 | Molecular Diagnostics |
MDx provides a highly sensitive, fully automated approach that streamlines the diagnosis-to-treatment process.
Read MorePosted by Judy O'Rourke | Apr 12, 2013 | Cancer, Information Technology, Miscellaneous |
In a recent blog post, Curt Johnson, COO, Orchard Software Corp, reflects on the future role of clinical labs in the changing landscape of health care.
Read MorePosted by Judy O'Rourke | Mar 27, 2013 | Miscellaneous |
Diagnostic development for microbiology and virology labs trends toward panels to improve time to treatment and long-term cost.
Read MorePosted by Judy O'Rourke | Mar 19, 2013 | Miscellaneous |
This categorization makes the benefits of this testing platform available to all Moderate Complexity labs in US hospitals and clinics, so they can now offer the company’s rapid, simple molecular test for each of these pathogens.
Read MorePosted by Judy O'Rourke | Mar 13, 2013 | Dementias & Alzheimer’s |
Luminex will be responsible for development, regulatory submission, and commercialization of the candidate companion diagnostic device, which will employ Luminex’s xMAP Technology.
Read More